• Home
  • Leadership
    • Management Team
    • Advisors
    • Scientific Advisory Board
    • Board of Directors
  • Therapeutic Programs
  • Media
  • Contact
100+ companies will participate in CED’s Venture Connect – here’s who made the cut

100+ companies will participate in CED’s Venture Connect – here’s who made the cut

by Damon Race | Feb 5, 2021 | In the News

by WRAL TechWire — January 29, 2021 RESEARCH TRIANGLE PARK – More than 100 startups and emerging entrepreneurial companies will participate in the Venture Connect 2021 summit, the Council for Entrepreneurial Development announced today. The event is set for March...

Recent Posts

  • GeneVentiv Invited to Present at BioPharm America 2023
  • Rare Disease Advisor – An Interview with Damon Race, President and CEO of GeneVentiv Therapeutics
  • GeneVentiv Welcomes New Advisors
  • GeneVentiv Invited to Present in Labcorp’s Symposium at the 26th Annual Meeting of the American Society of Cell and Gene Therapy
  • GeneVentiv Invited to Present at The National Hemophilia Foundation’s 17th Workshop

Recent Comments

    Archives

    • August 2023
    • April 2023
    • February 2023
    • January 2023
    • September 2022
    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Truck.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.